Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 21 Jan 21 EFFECT Notice of effectiveness
- 21 Jan 21 424B4 Prospectus supplement with pricing info
-
19 Jan 21 S-1 IPO registration
ATHA similar filings
Filing view
External links
Exhibit 23.1
Consent of Ernst and Young, LLP, Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated July 24, 2020, except for Note 17(a), 17(g), 17(h) and 17(i), as to which the date is September 14, 2020, in the Registration Statement (Form S-1) and related Prospectus of Athira Pharma, Inc. dated January 19, 2021.
/s/ Ernst & Young LLP
Seattle, Washington
January 19, 2021